证券记录 · 已归档季度
SRRK
Scholar Rock Holding Corporation · Healthcare · Biotechnology
19被追踪持有人
-2Δ持有人
52.36M持有股份
$1.95B报告持仓市值
+0新建仓位
−3清仓
动量输入（同类管理人）：
持有人广度 -9.5% ·
股份流向 +2.8% ·
净新建仓位 -15.8%
· 公式
集中增持：持股数量上升，持有人数量减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 5.86K | $247,641 | n/a | n/a |
| Q2 2026 | 105 | +5 | 87.18M | $4.79B | +10 | −4 |
| Q1 2026 | 102 | +4 | 76.34M | $3.75B | +8 | −5 |
| Q4 2025 | 97 | -1 | 72.93M | $3.21B | +2 | −2 |
| Q3 2025 | 19 | -2 | 52.36M | $1.95B | n/a | −3 |
| Q2 2025 | 19 | +1 | 48.51M | $1.72B | +1 | n/a |
| Q1 2025 | 15 | 0 | 24.83M | $798.16M | n/a | n/a |
| Q4 2024 | 15 | +1 | 26.21M | $1.13B | +2 | −1 |
| Q3 2024 | 13 | 0 | 15.70M | $125.78M | +1 | −1 |
| Q2 2024 | 13 | n/a | 12.73M | $106.08M | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 14.01M | +1.3% | $521.81M | 0.0% | ▲ Add | 2 | SEC ↗ ×4 |
| 2 | T. Rowe Price ✦ | 6.88M | -21.4% | $256.33M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 3 | BlackRock ✦ (被动) | 6.76M | +1.0% | $251.75M | 0.0% | ▲ Add | 2 | SEC ↗ ×15 |
| 4 | The Vanguard Group ✦ (被动) | 4.91M | +1.1% | $183.03M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 5 | Wellington Management ✦ | 4.55M | +124.5% | $169.29M | 0.0% | ▲ Add | 6 | SEC ↗ ×8 |
| 6 | State Street Global Advisors ✦ (被动) | 3.76M | +22.4% | $140.14M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | Geode Capital Management ✦ (被动) | 1.95M | +3.6% | $72.81M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 8 | Adage Capital Partners ✦ | 1.95M | +60.6% | $72.69M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 9 | Goldman Sachs Group ✦ | 1.56M | n/a | $58.21M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 10 | JPMorgan Chase ✦ | 1.43M | n/a | $53.18M | 0.0% | n/c | 1 | SEC ↗ ×16 |
| 11 | Capital World Investors ✦ | 1.13M | 0.0% | $42.03M | 0.0% | Held | 4 | SEC ↗ |
| 12 | Point72 Asset Management ✦ | 1.01M | +660.7% | $37.49M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 13 | Marshall Wace ✦ | 973.91K | -40.6% | $36.27M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 14 | Morgan Stanley ✦ | 604.00K | n/a | $22.49M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 15 | Fisher Asset Management ✦ | 533.18K | +29.3% | $19.86M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 16 | Two Sigma Investments ✦ | 159.07K | -29.6% | $5.92M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 134.61K | -86.2% | $5.01M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 18 | AQR Capital Management ✦ | 21.18K | -9.9% | $788,594 | 0.0% | ▼ Trim | 6 | SEC ↗ ×4 |
| 19 | D. E. Shaw & Co. ✦ | 18.49K | -86.4% | $688,568 | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Norges Bank | $41.63M | 曾为 0.0% |
| Renaissance Technologies | $10.31M | 曾为 0.0% |
| Millennium Management | $330,044 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 274 持有人, 132.63M 股份, $6.20B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
Aug 14
SC 13G/A: Redmile Group, LLC
Aug 13
SC 13G/A: Invus Global Management, LLC
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据